ATE534396T1 - Probiotische mikroorganismen zur verbesserung der muskulären funktion - Google Patents

Probiotische mikroorganismen zur verbesserung der muskulären funktion

Info

Publication number
ATE534396T1
ATE534396T1 AT03765107T AT03765107T ATE534396T1 AT E534396 T1 ATE534396 T1 AT E534396T1 AT 03765107 T AT03765107 T AT 03765107T AT 03765107 T AT03765107 T AT 03765107T AT E534396 T1 ATE534396 T1 AT E534396T1
Authority
AT
Austria
Prior art keywords
gut
probiotic microorganisms
muscular function
improve muscular
probiotics
Prior art date
Application number
AT03765107T
Other languages
English (en)
Inventor
Irene Corthesy-Theulaz
De Bercik Elena Verdu
Premysl Bercik
Stephen Collins
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29797269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE534396(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE534396T1 publication Critical patent/ATE534396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03765107T 2002-07-23 2003-07-23 Probiotische mikroorganismen zur verbesserung der muskulären funktion ATE534396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078064A EP1384483A1 (de) 2002-07-23 2002-07-23 Probiotische Mikroorganismen zur Behandlung von Colon Irritabile durch die Verbesserung der neuromuskulären Darmfunktion
PCT/EP2003/008076 WO2004009103A1 (en) 2002-07-23 2003-07-23 Probiotics for gut neuromuscular functions

Publications (1)

Publication Number Publication Date
ATE534396T1 true ATE534396T1 (de) 2011-12-15

Family

ID=29797269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03765107T ATE534396T1 (de) 2002-07-23 2003-07-23 Probiotische mikroorganismen zur verbesserung der muskulären funktion

Country Status (18)

Country Link
US (1) US8021656B2 (de)
EP (2) EP1384483A1 (de)
JP (1) JP2005538087A (de)
KR (1) KR20050025978A (de)
CN (1) CN100480370C (de)
AT (1) ATE534396T1 (de)
AU (1) AU2003250149B2 (de)
BR (1) BR0313185A (de)
CA (1) CA2493255A1 (de)
ES (1) ES2376664T3 (de)
IL (1) IL166442A0 (de)
MX (1) MXPA05000880A (de)
NO (1) NO20050896L (de)
NZ (1) NZ538335A (de)
PT (1) PT1531841E (de)
RU (2) RU2490325C2 (de)
WO (1) WO2004009103A1 (de)
ZA (1) ZA200501559B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337861B2 (en) * 2003-01-09 2012-12-25 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
EP2351492B1 (de) * 2005-02-28 2014-08-20 N.V. Nutricia Probiotische Bakterien enthaltendes Nahrungsmittel
CN101217886A (zh) * 2005-07-20 2008-07-09 荷兰联合利华有限公司 含有有益霉菌和/或酵母的可食用产品
US8246946B2 (en) * 2005-09-27 2012-08-21 Cobb & Associates Treatment of bipolar disorder utilizing anti-fungal compositions
ES2381211T3 (es) 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
RU2448720C2 (ru) 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
MX2008015031A (es) * 2006-05-26 2008-12-05 Nestec Sa Metodos de uso y composiciones nutritivas de extracto de touchi.
KR101521123B1 (ko) 2006-05-28 2015-05-19 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
PL2209527T3 (pl) 2007-10-11 2013-03-29 Dupont Nutrition Biosci Aps Kompozycje farmaceutyczne zawierające probiotyki L.acidophilus i Bifidobacterium lactis do stosowania w leczeniu zaburzenia czynnościowego jelit
EP2072053B1 (de) * 2007-12-21 2012-11-07 Compagnie Gervais Danone Verfahren zur Verringerung des Bauchumfangs durch Verabreichung einer Bakterie der Gattung Bifidobacterium
CA2724554A1 (en) * 2008-05-15 2009-11-19 Youdocs, Llc Methods and systems for improving human health using targeted probiotics
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
EP2216034A1 (de) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus-helveticus-CNCM I-4095 und Gewichtskontrolle
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
US10576110B2 (en) * 2009-05-11 2020-03-03 Societe Des Produits Nestle S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
EP2251020A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Kurzzeitige Hochtemperaturbehandlung erzeugt mikrobielle Zubereitungen mit entzündungshemmenden Profilen
TR201807143T4 (tr) 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
CN102905712B (zh) * 2010-01-28 2015-12-16 Ab－生物学有限公司 用于治疗肠炎的益生菌组合物
US8858933B2 (en) 2010-08-10 2014-10-14 Chr. Hansen A/S Nematicidal composition comprising bacillus subtilis and bacillus licheniformis
EP2455094A1 (de) * 2010-11-11 2012-05-23 Nestec S.A. Nicht replizierende probiotische Mikroorganismen als Schutz vor Magen-Darm-Infektionen bei Kindern
JP5681533B2 (ja) * 2011-03-14 2015-03-11 ビオフェルミン製薬株式会社 消化管痛の予防又は軽減剤
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
US20130045185A1 (en) * 2011-08-18 2013-02-21 Dupont Nutrition Biosciences Aps Strains and methods useful for mycotoxins
EP2609813A1 (de) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 zur Entwicklung des enterischen Nervensystems
US20130251829A1 (en) 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
CA2885537C (en) * 2012-09-20 2021-11-23 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
EP2912163A1 (de) * 2012-10-25 2015-09-02 Compagnie Gervais Danone Streptococcus thermophilus-stämme zur behandlung einer infektion mit helicobacter pylori
WO2014096901A1 (en) * 2012-12-18 2014-06-26 Compagnie Gervais Danone Strain of bifidobacterium animalis ssp. animalis
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
TR201815566T4 (tr) 2013-06-03 2018-11-21 Proprev Ab Prevotella'dan en az bir bakteri suşu kullanarak obezite, metabolik sendrom, tip 2 diyabet, kardiyovasküler hastalıklar, demans, alzheimer hastalığı ve enflamatuvar bağırsak hastalığının tedavisi.
ES2683190T3 (es) * 2013-08-09 2018-09-25 Ab-Biotics S.A. Probiótico para el llanto infantil excesivo
CN103497988B (zh) * 2013-09-23 2014-10-29 广州康代生物科技有限公司 一种安全高效乳酸菌产品的发酵生产方法
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
RU2608871C1 (ru) * 2015-11-06 2017-01-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятский государственный университет" Штамм бактерий Lactobacillus paracasei 1, используемый для приготовления пробиотического препарата
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN105767507B (zh) * 2016-03-30 2020-12-01 遂平广源饲料科技有限公司 一种饲料用微生态制剂、无抗饲料及其制备方法
KR101765559B1 (ko) 2016-09-27 2017-08-07 이대희 노루궁뎅이버섯을 포함하는 프로바이오틱스 조성물
KR20210141920A (ko) * 2018-12-21 2021-11-23 킴벌리-클라크 월드와이드, 인크. 요실금, 과민성 방광, 또는 월경 경련을 예방 또는 치료하기 위한 조성물 및 방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
CN1099289C (zh) * 1997-08-01 2003-01-22 北京东方百信生物技术有限公司 改善肠道生态平衡的微生物制剂及其工艺
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
IL145080A0 (en) * 1999-03-11 2002-06-30 Nestle Sa Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
EP1034787A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
EP1034788A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Milchsäure Bakterienstämme zur Verhinderung von Diarrhöe
ES2321797T3 (es) * 1999-08-05 2009-06-12 Societe Des Produits Nestle S.A. Bifidobacterias que previenen la diarrea causada por bacterias patogenicas.
AU784898B2 (en) * 2000-01-18 2006-07-20 Societe Des Produits Nestle S.A. Pet food composition for treating helicobacter species in pets
WO2001070246A1 (en) * 2000-03-24 2001-09-27 Societe Des Produits Nestle S.A. Use of lactic acid bacterium for the treatment of peritonitis
CN1444484A (zh) * 2000-06-19 2003-09-24 穆科普罗泰科有限公司 用益生菌对粘膜表面的细菌或病毒感染进行治疗或免疫治疗及用于此的组合物
IT1320772B1 (it) * 2000-11-02 2003-12-10 Proge Farm Srl Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
DE60231809D1 (de) * 2001-02-19 2009-05-14 Nestle Sa
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Also Published As

Publication number Publication date
NZ538335A (en) 2007-04-27
RU2346036C2 (ru) 2009-02-10
WO2004009103A1 (en) 2004-01-29
RU2005104950A (ru) 2005-12-10
CN1678329A (zh) 2005-10-05
AU2003250149B2 (en) 2009-01-22
EP1531841A1 (de) 2005-05-25
IL166442A0 (en) 2006-01-15
CN100480370C (zh) 2009-04-22
EP1384483A1 (de) 2004-01-28
EP1531841B1 (de) 2011-11-23
KR20050025978A (ko) 2005-03-14
CA2493255A1 (en) 2004-01-29
MXPA05000880A (es) 2006-01-24
AU2003250149A1 (en) 2004-02-09
US20070128178A1 (en) 2007-06-07
PT1531841E (pt) 2012-02-01
US8021656B2 (en) 2011-09-20
NO20050896L (no) 2005-04-18
BR0313185A (pt) 2005-06-21
ZA200501559B (en) 2006-05-31
JP2005538087A (ja) 2005-12-15
ES2376664T3 (es) 2012-03-15
RU2490325C2 (ru) 2013-08-20
RU2008132327A (ru) 2010-02-10

Similar Documents

Publication Publication Date Title
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
DK1305036T3 (da) Næringsmiddelsammensætning
DE60139554D1 (de) Probiotika zur primären prävention atopischer erkrankungen
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
NZ599302A (en) Preventing diseases in infants delivered via caesarean section
IL144184A0 (en) Use of lactobacillus salivarius
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
DE602004006133D1 (de) Neue galactooligosaccharidzusammensetzung und herstellung davon
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
EP1498039A4 (de) Lebende zellpräparate, die milchsäurebakterium als wirkstoff enthalten, sowie milchsäurebakteriumhaltige nahrungsmittel
ATE354964T1 (de) Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen
DK1643861T3 (da) Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter
WO2003053474A3 (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut
AU2003249856A1 (en) Rapidly disintegrating tablet
EE200300220A (et) Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod
ATE291353T1 (de) Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
PL1853308T3 (pl) Podawany drogą pokarmową preparat farmaceutyczny dla ryb, jego sposób wytwarzania oraz jego zastosowanie
CN107683999A (zh) 有利于口腔健康的益生菌固体饮料
CN118924797A (zh) 一种含改善口腔与肠道菌群的益生菌的组合物和口腔微泡腾片及其应用
Chawla et al. Safety issues in probiotic use
RU2002129937A (ru) Штамм бактерий bacillus subtilis, используемый для получения пробиотического препарата, предназначенного для профилактики и лечения желудочно-кишечных заболеваний сельскохозяйственных животных, птицы и рыбы
KR20040038401A (ko) 구내 종양 예방 및 조직 재생 분말